Search All UT System Experts

A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse

Benjamin M. Greenberg, James D. Bowen, Enrique Alvarez, Moses Rodriguez, Anthony O. Caggiano, Arthur E. Warrington, Ping Zhao, Andrew Eisen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse'. Together they form a unique fingerprint.

Medicine & Life Sciences